MIRASOL PATHOGEN REDUCTION TECHNOLOGY MODULATES PLATELET OXIDATIVE STRESS

被引：0
|
作者：
Johnson, L. N. [1 ]
Marks, D. C. [1 ]
机构：
[1] Australian Red Cross Blood Serv, Alexandria, Australia
来源：
VOX SANGUINIS | 2013年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [31] Photochemical Inactivation of Hepatitis E Virus (HEV) in Platelet Samples (PCs) using Mirasol Pathogen Reduction Technology (PRT) system
    Owada, T.
    Kaneko, M.
    Matsumoto, C.
    Igarashi, M.
    Uchida, S.
    Satake, M.
    Tadokoro, K.
    TRANSFUSION, 2013, 53 : 215A - 215A
  • [32] Clinical Performance of Mirasol® Pathogen Reduction Technology Treated Platelets During Routine Use
    Antelo Caamano, M.
    Zalba Marcos, S.
    Ayape Puyales, L.
    Aranguren Azparren, A.
    Aranburu, E.
    Marschner, S.
    Cardoso, M.
    TRANSFUSION, 2011, 51 : 58A - 59A
  • [33] QUALITY CONTROL OF FIBRINOGEN CONCENTRATE FROM PLASMA TREATED IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY
    Lachert, E.
    Kubis, J.
    Antoniewicz-Papis, J.
    Rosiek, A.
    Potocka, E.
    Poglod, R.
    Letowska, M.
    VOX SANGUINIS, 2013, 105 : 154 - 154
  • [34] Photochemical inactivation of Chikungunya virus using the Mirasol® pathogen reduction technology (PRT) system
    Keil, S.
    Vanlandingham, D.
    Tsetsarkin, K.
    Goodrich, R.
    Higgs, S.
    TRANSFUSION, 2008, 48 (02) : 89A - 89A
  • [35] Evaluation of navigant's MIRASOL pathogen reduction technology system for reduction of Babesia microti in apheresis platelets and plasma
    Tonnetti, L.
    Proctor, M. C.
    Reddy, H. L.
    Goodrich, R. P.
    Leiby, D. A.
    TRANSFUSION, 2007, 47 (03) : 131A - 131A
  • [36] USE OF MIRASOL® PATHOGEN REDUCTION TECHNOLOGY (PRT) TO PREVENT CMV TRANSMISSION IN A MOUSE TRANSFUSION MODEL
    Roback, D.
    Newman, L.
    Saakadze, N.
    Keil, D.
    Goodrich, P.
    VOX SANGUINIS, 2010, 99 : 256 - 256
  • [37] Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system
    Vanlandingham, Dana L.
    Keil, Shawn D.
    Horne, Kate McElroy
    Pyles, Richard
    Goodrich, Raymond P.
    Higgs, Stephen
    TRANSFUSION, 2013, 53 (02) : 284 - 290
  • [38] MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATMENT OF ORBISAC BUFFY COAT PLATELETS SUSPENDED IN ADDITIVE SOLUTION
    Maia, S.
    Rio, N.
    Marques, S.
    Rouse, L.
    VOX SANGUINIS, 2010, 99 : 245 - 246
  • [39] Mirasol™ pathogen reduction technology:: Riboflavin-based process retains functional activities of immunoglobulins
    Kumar, V
    Motheral, T
    Luzniak, G
    Monique, J
    Goodrich, R
    TRANSFUSION, 2003, 43 (09) : 80A - 80A
  • [40] Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis
    Janetzko, Karin
    Hinz, Katharina
    Marschner, Susanne
    Goodrich, Ray
    Klueter, Harald
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (05) : 309 - 315
12345